( compliance are multifactorial said s...)Separate Sets of Research Show Treatment Improved Quality of Life,,,in as Early as Three Weeks; Patient Adherence to Medication is,,,Multifactorial,Health

compliance are multifactorial," said study lead author Sunanda Kane, M.D., Associate Professor of Medicine, Section of Gastroenterology and Nutrition at the University of Chicago. "This information, adds to the pool of knowledge physicians have surrounding UC treatment to help them better understand and treat their patients."

The retrospective cohort study used records of health service utilization from the Thomson Medstat MarketScan(R) Research database. Treatment initiation was defined as 5-ASA use from October 2002 - September 2004 with no 5-ASA use in the prior six months. 5-ASA prescription refill activity was captured at three months. Parameters of interest at index date and 12 months prior were compared between patients who refilled their prescriptions at three months, and those who did not.

In addition to its well-known consumer brands, P&G develops and markets a gastrointestinal platform that extends across pharmaceutical and over-the- counter brands. One of these brands is Asacol Delayed-Release Tablets, available by prescription only, which is indicated for ulcerative colitis (UC), a form of inflammatory bowel disease (IBD).(1) Additional information about Asacol can be found by visiting www.Asacol.com.

About Ulcerative Colitis

UC involves inflammation of the lining of the colon and rectum. It varies in clinical severity with patients having mild, moderate or severe disease. Treatment depends on the extent and severity of disease.

UC causes flares followed by periods of remission. During a flare, in which the rectum or colon become inflamed, people experience symptoms such as diarrhea, rectal bleeding, abdominal cramping and an urgent need to go to the bathroom. Flares can vary in duration and intensity. While UC is a lifelong condition, medication may help control flares.

UC affects people of a
'"/>

Page: 1 2 3 4 5
Related medicine technology :

1. Study Shows Advantages of Complete Phase Ib Trial Over Separate Phase I Trials
2. NIEHS Researchers Identify Enzyme Critical in DNA Replication
3. Stanford Researchers Find Brain Pathway of Depression in Rats
4. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
5. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
6. Researchers Discover Method for Identifying How Cancer Evades the Immune System
7. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
8. Fact Sheet: Advancing Stem Cell Research While Respecting Moral Boundaries
9. President Bush Ignores Americas Plea for Support of Stem Cell Research
10. Researchers Discover Gene For Rare Skin Disorder
11. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act